Data gathered: December 26
Alternative Data for LeMaitre Vascular
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 10 | Sign up | Sign up | Sign up | |
Sentiment | 100 | Sign up | Sign up | Sign up | |
Webpage traffic | 7,000 | Sign up | Sign up | Sign up | |
Employee Rating | 64 | Sign up | Sign up | Sign up | |
Google Trends | N/A | Sign up | Sign up | Sign up | |
Patents | N/A | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 477 | Sign up | Sign up | Sign up | |
Twitter Followers | 383 | Sign up | Sign up | Sign up | |
Twitter Mentions | 6 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 349 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
ESG | 28 | Sign up | Sign up | Sign up | |
Business Outlook | 42 | Sign up | Sign up | Sign up | |
Linkedin Employees | N/A | Sign up | Sign up | Sign up |
About LeMaitre Vascular
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
Price | $92.41 |
Target Price | Sign up |
Volume | 9,060 |
Market Cap | $2.08B |
Year Range | $62.43 - $107.97 |
Dividend Yield | 0.69% |
PE Ratio | 50.9 |
Analyst Rating | 71% buy |
Industry | Medical & Dental Instruments |
In the news
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of “Moderate Buy” by AnalystsDecember 23 - ETF Daily News |
|
LeMaitre Vascular Announces $150 Million Convertible Senior Notes OfferingUnited States-based medical device company LeMaitre Vascular, Inc. (NASDAQ: LMAT) revealed its plans for a substantial financial move on December 16, 2024. The company discloseDecember 19 - ETF Daily News |
|
A Look At The Intrinsic Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)December 18 - Yahoo Entertainment |
|
LeMaitre Vascular : Prices $150 Million Convertible Senior Notes Form 8 KDecember 16 - Finnhub |
|
LeMaitre Vascular Prices $150 Million Convertible Senior NotesDecember 16 - Finnhub |
|
LeMaitre Vascular Announces Proposed Convertible Senior Notes OfferingDecember 16 - GlobeNewswire |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q3 '24 | 110M | 39M | 37M | 11M | 15M | 0.490 |
Q2 '24 | 112M | 39M | 38M | 12M | 16M | 0.520 |
Q1 '24 | 107M | 39M | 37M | 9.9M | 13M | 0.440 |
Q4 '23 | 49M | 43M | 33M | 8.5M | 12M | 0.380 |
Q3 '23 | 47M | 36M | 31M | 7.5M | 11M | 0.330 |
Insider Transactions View All
Jasinski Lawrence J filed to sell 5,111 shares at $103.5. November 22 '24 |
Ross Bridget A filed to sell 2,278 shares at $101.5. November 19 '24 |
SHADAN MARTHA filed to sell 1,304 shares at $103.4. November 15 '24 |
SHADAN MARTHA filed to sell 1,700 shares at $103.4. November 15 '24 |
Roberts David B filed to sell 14,114 shares at $82.1. August 15 '24 |
Similar companies
Read more about LeMaitre Vascular (LMAT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of LeMaitre Vascular?
The Market Cap of LeMaitre Vascular is $2.08B.
What is LeMaitre Vascular's PE Ratio?
As of today, LeMaitre Vascular's PE (Price to Earnings) ratio is 50.9.
What is the current stock price of LeMaitre Vascular?
Currently, the price of one share of LeMaitre Vascular stock is $92.41.
How can I analyze the LMAT stock price chart for investment decisions?
The LMAT stock price chart above provides a comprehensive visual representation of LeMaitre Vascular's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LeMaitre Vascular shares. Our platform offers an up-to-date LMAT stock price chart, along with technical data analysis and alternative data insights.
Does LMAT offer dividends to its shareholders?
Yes, LeMaitre Vascular (LMAT) offers dividends to its shareholders, with a dividend yield of 0.69%. This dividend yield represents LeMaitre Vascular's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LeMaitre Vascular in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of LeMaitre Vascular?
Some of the similar stocks of LeMaitre Vascular are Align Technology, Dentsply, iRhythm Technologies, NovoCure, and Silk Road Medical.
.